EssilorLuxottica Societe Anonyme Total Assets 2011-2020 | ESLOY
EssilorLuxottica Societe Anonyme total assets from 2011 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
- EssilorLuxottica Societe Anonyme total assets for the quarter ending June 30, 2020 were $58.893B, a 316.36% increase year-over-year.
- EssilorLuxottica Societe Anonyme total assets for 2019 were $58.893B, a 7.78% increase from 2018.
- EssilorLuxottica Societe Anonyme total assets for 2018 were $54.644B, a 293.04% increase from 2017.
- EssilorLuxottica Societe Anonyme total assets for 2017 were $13.903B, a 4.56% decline from 2016.
| EssilorLuxottica Societe Anonyme Annual Total Assets (Millions of US $) |
|
|---|---|
| 2019 | $58,893 |
| 2018 | $54,644 |
| 2017 | $13,903 |
| 2016 | $14,566 |
| 2015 | $13,293 |
| 2014 | $14,342 |
| 2013 | $10,065 |
| 2012 | $8,883 |
| 2011 | $8,577 |
| 2010 | $6,923 |
| EssilorLuxottica Societe Anonyme Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2019-12-31 | $58,893 |
| 2018-12-31 | $54,644 |
| 2018-06-30 | $15,023 |
| 2017-12-31 | $13,903 |
| 2017-06-30 | $14,145 |
| 2016-12-31 | $14,566 |
| 2015-12-31 | $13,293 |
| 2015-06-30 | $12,875 |
| 2014-12-31 | $14,342 |
| 2014-06-30 | $14,043 |
| 2013-12-31 | $10,065 |
| 2013-06-30 | $9,315 |
| 2012-12-31 | $8,883 |
| 2012-06-30 | $8,685 |
| 2011-12-31 | $8,577 |
| 2011-06-30 | $7,569 |
| 2010-12-31 | $6,923 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $32.633B | $19.479B |
| EssilorLuxottica Soci?t? is involved in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. The company's brand portfolio consists of Ray-Ban, Oakley, Varilux(R), Transitions(R), Sunglass Hut and LensCrafters. EssilorLuxottica Soci?t?, formerly known as Essilor International Soci?t? Anonyme, is based in Paris, France. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $197.264B | 35.33 |
| Medtronic (MDT) | Ireland | $157.229B | 31.92 |
| Stryker (SYK) | United States | $90.938B | 34.03 |
| Boston Scientific (BSX) | United States | $52.022B | 30.53 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.179B | 0.00 |
| Baxter (BAX) | United States | $40.886B | 24.55 |
| Zimmer Biomet Holdings (ZBH) | United States | $33.189B | 27.32 |
| ResMed (RMD) | United States | $30.667B | 41.49 |
| Terumo (TRUMY) | Japan | $30.199B | 45.70 |
| Sunny Optical Technology (SNPTF) | China | $26.703B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $18.823B | 0.00 |
| Insulet (PODD) | United States | $18.539B | 639.09 |
| Bio-Rad Laboratories (BIO) | United States | $17.933B | 68.00 |
| Canopy Growth (CGC) | Canada | $12.429B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $11.022B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $10.836B | 50.22 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $9.406B | 0.00 |
| William Demant Holdings (WILYY) | Denmark | $8.997B | 0.00 |
| Quidel (QDEL) | United States | $8.602B | 21.43 |
| Hill-Rom Holdings (HRC) | United States | $6.675B | 18.07 |
| TG Therapeutics (TGTX) | United States | $6.525B | 0.00 |
| Haemonetics (HAE) | United States | $6.383B | 46.38 |
| Perrigo (PRGO) | Ireland | $5.966B | 10.51 |
| Envista Holdings (NVST) | United States | $5.709B | 38.45 |
| ICU Medical (ICUI) | United States | $4.521B | 33.93 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $4.511B | 0.00 |
| Neogen (NEOG) | United States | $4.449B | 73.30 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.214B | 0.00 |
| National Vision Holdings (EYE) | United States | $3.941B | 103.49 |
| Aphria (APHA) | Canada | $3.708B | 0.00 |
| AdaptHealth (AHCO) | United States | $3.292B | 169.23 |
| Agios Pharmaceuticals (AGIO) | United States | $3.163B | 0.00 |
| NanoString Technologies (NSTG) | United States | $3.131B | 0.00 |
| NuVasive (NUVA) | United States | $2.921B | 42.19 |
| AtriCure (ATRC) | United States | $2.548B | 0.00 |
| Quanterix (QTRX) | United States | $2.356B | 0.00 |
| Owens & Minor (OMI) | United States | $2.036B | 21.47 |
| InMode (INMD) | Israel | $1.848B | 41.59 |
| Cardiovascular Systems (CSII) | United States | $1.792B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $1.707B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.320B | 1344.33 |
| Cerus (CERS) | United States | $1.212B | 0.00 |
| MacroGenics (MGNX) | United States | $1.157B | 0.00 |
| Omeros (OMER) | United States | $1.113B | 0.00 |
| PetIQ (PETQ) | United States | $1.074B | 61.36 |
| Lantheus Holdings (LNTH) | United States | $1.032B | 18.37 |
| BellRing Brands (BRBR) | United States | $0.950B | 40.17 |
| Meridian Bioscience (VIVO) | United States | $0.931B | 20.18 |
| OraSure Technologies (OSUR) | United States | $0.927B | 0.00 |
| HEXO (HEXO) | Canada | $0.881B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.868B | 45.90 |
| Phibro Animal Health (PAHC) | United States | $0.864B | 18.41 |
| Vapotherm (VAPO) | United States | $0.844B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.723B | 205.11 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.660B | 46.92 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.634B | 0.00 |
| Female Health (VERU) | United States | $0.623B | 0.00 |
| Surmodics (SRDX) | United States | $0.602B | 366.50 |
| Zynex (ZYXI) | United States | $0.574B | 53.29 |
| Surface Oncology (SURF) | United States | $0.500B | 0.00 |
| Chimerix (CMRX) | United States | $0.497B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.418B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.370B | 0.00 |
| Bovie Medical (APYX) | United States | $0.340B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.329B | 11.68 |
| Utah Medical Products (UTMD) | United States | $0.323B | 29.50 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.262B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.236B | 0.00 |
| Evolus (EOLS) | United States | $0.197B | 0.00 |
| Exagen (XGN) | United States | $0.194B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.137B | 0.00 |
| Akerna (KERN) | United States | $0.125B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.119B | 0.00 |
| Fonar (FONR) | United States | $0.119B | 17.42 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.117B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.112B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.102B | 0.00 |
| Brainsway (BWAY) | Israel | $0.087B | 0.00 |
| Glucose Health (GLUC) | United States | $0.079B | 0.00 |
| Nephros (NEPH) | United States | $0.076B | 0.00 |
| United-Guardian (UG) | United States | $0.065B | 15.74 |
| GUARDION HEALTH (GHSI) | United States | $0.058B | 0.00 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.040B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.023B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.021B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.014B | 0.00 |
| Conatus Pharmaceuticals (HSTO) | United States | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.009B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 7.44 |
